Overexpression of TSPAN4 in esophageal squamous cell carcinoma (ESCC) cell lines notably promoted resistance to paclitaxel (PTX) by inhibiting cell apoptosis (Zhao et al., 2019b). Here, TSPAN4 is linked to esophageal squamous cell carcinoma.